Mesotheliomas Pleural Clinical Trials

17 clinical trials for Mesotheliomas Pleural across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Sacituzumab Govitecan in People With Mesothelioma — RECRUITING · PHASE2
• Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma — RECRUITING · NA
• Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) — RECRUITING · PHASE1
• The IMmunotherapy Pleural 5-ALA PDT — RECRUITING · PHASE2
• Immune Microenvironment and Gene Expression Profiling in Mesothelioma — RECRUITING
• dENdritic Cell Therapy Combined With SURgEry in Mesothelioma — RECRUITING · PHASE1
• Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) — RECRUITING · PHASE3
• Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma — COMPLETED · PHASE1
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer — TERMINATED · PHASE1
• Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma — WITHDRAWN
• CAR T Cells in Mesothelin Expressing Cancers — COMPLETED · PHASE1
• Oral AMXT 1501 Dicaprate in Combination With IV DFMO — TERMINATED · PHASE1
• Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Ga-68 FAPI PET Before Immunotherapy — OTHER · NA
• Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors — OTHER · PHASE1

Refine this search